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Arthritis is a frequent complication of infection in humans with Borrelia burgdorferi. Weeks to months following the onset of
Lyme borreliosis, a histopathological reaction characteristic of synovitis including bone, joint, muscle, or tendon pain may occur.
A subpopulation of patients may progress to a chronic, debilitating arthritis months to years after infection which has been
classiﬁed as severe destructive Lyme arthritis. This arthritis involves focal bone erosion and destruction of articular cartilage.
Hamsters and mice are animal models that have been utilized to study articular manifestations of Lyme borreliosis. Infection of
immunocompetent LSH hamsters or C3H mice results in a transient synovitis. However, severe destructive Lyme arthritis can
be induced by infecting irradiated hamsters or mice and immunocompetent Borrelia-vaccinated hamsters, mice, and interferon-
gamma- (IFN-γ-) deﬁcient mice with viable B. burgdorferi. The hamster model of severe destructive Lyme arthritis facilitates
easy assessment of Lyme borreliosis vaccine preparations for deleterious eﬀects while murine models of severe destructive Lyme
arthritis allow for investigation of mechanisms of immunopathology.
1.Introduction
1.1. Lyme Borreliosis Background. Since its discovery in the
mid 1970s, Lyme borreliosis has become the most prevalent
tick-borne infectious illness in the United States [1]. Follow-
ing a brief early infection period that can be characterized
by constitutional symptoms [2] and the pathognomonic
erythema migrans [3], successive stages of the illness in
nontreated individuals can consist of a dissemination of the
etiologic agent Borrelia burgdorferi to multiple organ sites
and subsequent persistence of the spirochete. Consequences
of this activity are immunopathologies, with aﬄicted indi-
viduals presenting with cardiac [4], neurological [5, 6], and
musculoskeletal [7] abnormalities.
1.2. Synovitis and Severe Destructive Arthritis in Humans. In
early Lyme borreliosis, aﬄicted individuals may experience
joint, tendon, muscle, or bone pain. Subsequently, ﬁfty
to sixty percent display acute signs of arthritis, including
musculoskeletal pain without objective ﬁndings [7, 8].
Histopathological analyses of synovectomies and synovial
biopsies at this stage of Lyme borreliosis articular involve-
ment have described a hyperplastic synovitis [9]. Arthritic
involvement in late Lyme disease includes intermittent
episodes of joint pain, with 50–60% of such individuals
suﬀering from inﬂammatory arthritis with synovial eﬀusion
or pain on motion [7, 8]. Of these patients, 11% may
progress to a chronic and debilitating severe destructive
Lyme arthritis [7]. The increased severity of arthropathy at
this stage has been characterized as a synovial hyperplasia,
an inﬁltration of mononuclear cells into the synovium, a
formation of an inﬂammatory exudate over the lining of
synovial cells (pannus formation), a destruction of cartilage,
and as an erosion of bones and joints [10, 11].2 Clinical and Developmental Immunology
Early associations were hypothesized between the major
histocompatibility complex (MHC) class II alleles HLA-DR2
and HLA-DR4 and severe destructive Lyme arthritis [12, 13].
Furthermore, individuals aﬄicted with a severe destructive
Lyme arthritis that was refractory to antimicrobial therapy
predominately showed an HLA-DR4 speciﬁcity [14]. Gross
et al. [15] subsequently identiﬁed an immunodominant
epitope within B. burgdorferi outer surface protein A
(OspA) for T lymphocytes that may shoulder responsibility
for the induction of treatment-resistant severe destructive
Lyme arthritis. In support of this statement, Steere et al.
[16] showed that the majority of patients with late-stage,
antimicrobial-refractoryLymearthritispossessedatleastone
of the HLA-DR molecules known to bind to this putative
arthritogenic epitope of OspA while those individuals with
antimicrobial-responsive arthritis possessed these molecules
to a signiﬁcantly less-frequent degree. Moreover, extensive
investigations into identifying additional arthritogenic, T
lymphocyte-binding epitopes of B. burgdorferi [17]y i e l d e d
no more suitable candidate for further investigation into
inducersoflate-stageantimicrobial-refractoryLymearthritis
than the OspA163–175 epitope. Although OspA is considered
a leading candidate that induces arthritis in humans, other
B. burgdorferi antigens, as well as intrinsic host factors and
host HLA-DR alleles, may also play a role in the induction of
arthritis. Such considerations provide a tremendous impetus
for the elucidation of mechanisms that result in severe
destructive Lyme arthritis, especially when considering that
OspA or other antigens are prominent Lyme borreliosis
vaccine candidates.
It is known that two clinical entities of Lyme borreliosis
articular involvement occur in humans. It is critical to
makethedistinctionbetweensynovitisandseveredestructive
Lyme arthritis. This review will focus on the utility of the
hamster and murine models in experimental investigations
of severe destructive Lyme arthritis. Each animal model of an
articular condition analogous to that which aﬄicts humans
in early Lyme borreliosis will be discussed. This will be
followed by presentation of experimental models of severe
destructive Lyme arthritis. Beneﬁts and applications of these
models will subsequently be expounded upon.
2.HamsterModelsof Synovitisand
SevereDestructiveLymeArthritis
2.1. Synovitis. When immunocompetent adult London
School of Hygiene (LSH) hamsters were challenged in the
footpad with 106 live B. burgdorferi sensu stricto isolate 297,
a slight degree of tibiotarsal joint swelling was observed
between 10 and 14 days after inoculation [18]. In addi-
tion, histopathological changes were demonstrated in these
animals. Synovial hyperplasia with focal areas of ulceration
and overlying adherent ﬁbrin was present at one week of
infection. The majority of immune cells responsive to this
inoculum were neutrophilic in nature, with this inﬁltrate
involving the synovial and periarticular structures, including
the ﬁbrous capsule, periosteum, ligaments, tendons, and
tendon sheaths. Numerous spirochetes were also observed
through the use of silver impregnation staining techniques.
Such histological evidence of synovitis persisted for
approximately three weeks, after which both macroscopic
edema and histopathological involvement waned. Following
a 15-week observation of infected hamsters, histopatholog-
ical examination noted that subsynovial and periarticular
soft tissues contained increased ﬁbroblasts and collagen,
persistent small hypertrophic synovial villi were still evident,
and spirochetes were no longer seen. No destructive bone
erosion was reported. No edematous or histopathological
ﬁndingswereseeninhamsterschallengedinthefootpadwith
growth medium.
This model is used to investigate the innate immune
response to infection with B. burgdorferi. Since humans
develop arthritis weeks to months after infection, the
hamster model of synovitis is valuable for understanding the
early immune events that drive the neutrophilic response to
infection, induction of cytokines, and early antigenic pro-
cessingthatareresponsibleforthelaterinductionofadoptive
immunity. Most investigations using mice, hamsters, and
other animals have focused on this early stage of develop-
ment of arthritis. Therefore, there is considerable debate
over whether T lymphocytes are responsible for induction of
arthritis. Other animal models (see the following) that focus
on nonearly events strongly support a role forT lymphocytes
in the induction and resolution of arthritis. Most important,
the early innate immune responses responsible for the
induction of synovitis are directly connected to the T
lymphocyte responses that drive the more severe pathology
of severe destructive Lyme arthritis.
2.2. Irradiation Model of Severe Destructive Lyme Arthritis.
Adult LSH hamsters that were subjected to 550 rads of
gamma radiation manifested a tibiotarsal joint swelling
upon footpad challenge with 106 live B. burgdorferi 297
[18]. Edema peaked approximately ten days after challenge
and was found to be signiﬁcantly elevated over that of
nonirradiated infected hamsters throughout the ﬁrst ﬁve
weeks of observation. Furthermore, behavioral changes were
observed in the irradiated infected animals. These hamsters
were increasingly irritable and vicious, maneuvering about
their cages very slowly on their abdomens, dragging their
hind legs. Analogous behavior was not observed in nonirra-
diated infected hamsters.
Histopathological examination of infected irradiated
hamsters demonstrated a more severe and fulminate artic-
ular involvement. Greater synovial hyperplasia and hyper-
trophy were observed to the point that pannus formations
bridging synovial spaces were noted. Neutrophilic inﬁltrate
resulted in erosion of articular cartilage and superﬁcial
destruction of underlying bone. Increases in collagen forma-
tion and numbers of ﬁbroblasts were shown also to result
in ﬁbrosing ankylosis, loss of alignment of the articular
surfaces, and overall deformation of the joints [19]. This
animal model is used to evaluate the adoptive immune
responses that protect against infection. Cells or sera fromClinical and Developmental Immunology 3
immunized or naturally infected animals are transferred to
irradiated hamsters and then challenged with B. burgdorferi
to determine their role in protection. In addition, cells and
cytokines participating in preventing or augmenting the
arthritis can be determined.
2.3. Immunocompetent Model of Severe Destructive Lyme
Arthritis. The relevance of experimental hamsters was fur-
ther established with the advent of the immunocompetent
hamster model of severe destructive Lyme arthritis. When
Lim et al. [20] vaccinated adult LSH hamsters with formalin-
inactivated B. bissettii (formerly B. burgdorferi sensu stricto
isolate C-1-11) in aluminum hydroxide adjuvant (alum),
gross tibiotarsal joint edema was observed upon footpad
challenge with heterologous isolates of B. burgdorferi or with
B. bissettii prior to the induction of protective immunity.
Edema measurements demonstrated statistically signiﬁcant
increases in tibiotarsal swelling over those observed in
nonvaccinated hamsters challenged with multiple isolates
of B. burgdorferi. It was also shown that arthritis could be
induced using live spirochetes, heat-inactivated spirochetes,
or antimicrobial-treated organisms mixed in alum. Only
viable organisms, however, were required upon challenge to
elicit the arthritis.
Analogous to diﬀerences observed macroscopically,
histopathological examination revealed varying degrees of
arthritis severity in vaccinated and nonvaccinated ham-
sters following challenge with B. burgdorferi. Erosion of
articular cartilage, focal destruction of underlying bone,
and chronic hyperplasia and hypertrophy characterized by
pannus formation were observed in the synovia of hamsters
challenged with B. bissettii following a ﬁve-week vaccination
with B. bissettii in adjuvant. These animals also manifested a
cellular inﬁltrate of neutrophils, macrophages, lymphocytes,
mast cells, and plasma cells in the subsynovial and periartic-
ular tissues. In contrast, nonvaccinated hamsters challenged
with B. bissettii displayed an acute synovitis characterized by
acellularinﬂammatoryinﬁltratedevoidofpannusformation
or bone erosion. Severe destructive Lyme arthritis can also
be induced using other isolates of B. burgdorferi mixed
in alum and then infected with a homologous spirochete
before borreliacidal antibody develops or with a heterolo-
gous isolate when isolate-speciﬁc borreliacidal antibody is
present.
This model mimics how humans develop Lyme arthritis.
Humans develop Lyme arthritis many weeks after they are
infected/vaccinated by spirochetes that entered the host by
the bite of an infected tick. Persistence of the spirochete
or its antigens, such as OspA, in the nontreated individual
would initiate a series of immunological events in the
host that ﬁnally induce arthritis. By vaccinating hamsters,
the immunological events responsible for the induction of
arthritis are compressed from weeks into days. A major
concern with the hamster model of severe destructive Lyme
arthritis is the lack of immunological reagents that can be
utilized to decipher the immune components responsible for
the induction of arthritis.
2.3.1. Utilization of Hamster Models of Severe Destructive
Lyme Arthritis to Assess Protective Immunity. Af e a t u r e
common to both the irradiated and immunocompetent
LSH hamster models of severe destructive Lyme arthritis
is their utility in characterizing and monitoring protective
immunity. Schmitz et al. [21] reported that heat-inactivated
B. burgdorferi-immune sera were able to inactivate inocula
of live B. burgdorferi in the presence of complement in
an in vitro assay. These speciﬁc killing antibodies were
thus termed borreliacidal antibodies. To determine the
protective capability of these borreliacidal antibodies, irra-
diated hamsters received sera through adoptive transfer and
were subsequently challenged with B. burgdorferi. Irradiated
hamsters receiving sera with low titer of borreliacidal
antibody developed severe destructive Lyme arthritis while
hamsters receiving sera containing signiﬁcant borreliacidal
activity were protected from B. burgdorferi infection, as
well as the evocation of severe destructive Lyme arthritis.
In similar fashion, Callister et al. [22] used the irradiated
hamster model of severe destructive Lyme arthritis to
prove that humans generate a borreliacidal response upon
infection with B. burgdorferi.A d o p t i v et r a n s f e ro fs e r a
from humans with clinically diagnosed Lyme borreliosis
(signiﬁcantborreliacidalantibodyresponsedetectedinvitro)
protected irradiated hamsters from B. burgdorferi infection
and subsequent progression to severe destructive Lyme
arthritis, while transfer of sera from healthy individuals
(no borreliacidal activity detected in vitro)f a i l e dt op r o t e c t
hamstersfrominductionofseveredestructiveLymearthritis.
Taken together, these data suggest that in vitro borreliacidal
activity correlates with protection events in vivo.
Induction of these borreliacidal antibodies establishes
the eﬀectiveness of Lyme borreliosis vaccine preparations
[23]. When Jobe et al. [24] actively immunized irradiated
hamsters with a commercial canine whole cell Lyme bor-
reliosis vaccine, gross tibiotarsal joint swelling, and severe
destructive Lyme arthritis were induced in these animals
when challenged three weeks after vaccination with live B.
burgdorferi. Conversely, animals challenged ﬁve weeks after
vaccination were protected from such manifestations. Sim-
ilarly, when Lim et al. [20] vaccinated immunocompetent
hamsters with formalin-inactivated B. bissettii in aluminum
hydroxide, severe destructive Lyme arthritis was induced in
these animals when challenged with a homologous isolate
of B. burgdorferi at intervals of less than seven weeks
after immunization. By contrast, hamsters challenged with
B. bissettii seven and nine weeks after vaccination failed
to manifest severe destructive Lyme arthritis. Subsequent
experiments [25] revealed that hamsters vaccinated with
formalin-inactivated B. burgdorferi isolate 50772 in alu-
minum hydroxide were protected against a subsequent
homologous challenge at time points ranging from 5 to 18
weeks after vaccination. Severe destructive Lyme arthritis
was induced in vaccinated hamsters that were challenged
at intervals both earlier (10 days, 3 weeks) and later (24
weeks) than those which aﬀorded protection. These data
exemplify how irradiated and immunocompetent hamsters
have been used as an in vivo correlate to a common concern
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ﬁrst observed in vitro [24, 26], namely, relatively short
duration of protective borreliacidal antibody production.
Therefore, these models can be utilized to validate the
duration of protection induced in individuals receiving any
future Lyme borreliosis vaccine. They may also establish
the number of vaccinations required to establish long-term
protection.
Irradiated and immunocompetent hamster models of
severedestructiveLymearthritishavealsobeenimplemented
to investigate an additional pitfall with regard to Lyme
borreliosis vaccine preparations. Seroprotectivity is an index
of the ability of immune sera generated in one mammalian
hosttoprotect,viaadoptivetransfer,ana¨ ıverecipientanimal
against subsequent challenge. As an example, irradiated
hamsters that were passively immunized with sera generated
by the infection of hamsters with B. burgdorferi 297 were
protected from the induction of severe destructive Lyme
arthritis upon challenge with B. burgdorferi sensu stricto
isolate B31. Conversely, passive administration of anti-B.
burgdorferi 297 sera failed to protect irradiated hamsters
from the evocation of severe destructive Lyme arthritis upon
challenge with B. bissettii [27]. On the basis of these and
other data [28], Lovrich et al. established six seroprotective
groups of B. burgdorferi sensu lato isolates, with inherent
diﬀerences in seroprotectivity being partially reﬂective of
the worldwide distribution of B. burgdorferi sensu lato
isolates. Immunocompetent hamsters were utilized in a
similarfashiontoclassifyisolate-speciﬁcrOspApreparations
into analogous seroprotective groups [29], signaling an
additional concern pertaining to any new federally licensed
Lyme borreliosis vaccine preparations. These models can be
easily utilized to assess the degree of cross-protection and
development of a universal vaccine.
2.3.2. Utilization of Hamster Models of Severe Destructive
Lyme Arthritis to Assess the Role of Cell Populations in
Induction of Severe Destructive Lyme Arthritis. The ﬁndings
of Lim et al. [20] were important for an additional reason.
This published model of severe destructive Lyme arthritis
did not require the utilization of gamma radiation. This
allowed for elucidation of roles that certain cell populations
play in the induction of severe destructive Lyme arthritis in
the context of an immunocompetent mammalian host. Du
Chateau et al. [30] reported that macrophages play a direct
eﬀector role in the induction of severe destructive Lyme
arthritis.Macrophagesthatwereobtainedfromvaccinatedor
nonvaccinated LSH hamsters, exposed in vitro to formalin-
inactivated B. burgdorferi, and subsequently infused into
footpads of na¨ ıve recipients induced severe destructive Lyme
arthritisuponchallengewithB.burgdorferi.Boththeseverity
and onset of the arthritis were dependent on the number of
macrophagesinfusedintotherecipientfootpads.Inaddition,
macrophages not exposed to B .b u r g d o r f e r ii nv i t r ofailed to
induce severe destructive Lyme arthritis upon B. burgdorferi
challenge. Roles for T lymphocytes and subset populations
thereof, either alone [31, 32] or in synergy with macrophages
[33, 34], have been proposed in the pathology of severe
destructive Lyme arthritis. However, the value of the hamster
model of severe destructive Lyme arthritis in further studies
oftheimmunoregulation of severedestructiveLymearthritis
has been constrained due to the unavailability of many
hamster-speciﬁc molecular and immunological reagents.
2.3.3. Immunocompetent Model of Severe Destructive Lyme
Arthritis for Assessment of Lyme Borreliosis Vaccine Prepara-
tions. An extremely practical and relatively straightforward
application of theimmunocompetent LSHhamstermodel of
severe destructive Lyme arthritis involves safety assessment
of Lyme borreliosis vaccine preparations. Speculation that
the severe destructive Lyme arthritis was elicited in hamsters
only because a whole cell component of B. burgdorferi was
used as the immunogen was refuted by Croke et al. [35].
Vaccination of immunocompetent LSH hamsters with 30μg
of recombinant (r) OspA in alum primed these hosts for the
induction of gross macroscopic edema and corresponding
severe destructive Lyme arthritis upon footpad challenge
with both heterologous and homologous isolates of B.
burgdorferi. By contrast, hamsters that were vaccinated with
30μg of rOspA in alum and not subsequently challenged
with B. burgdorferi manifested no tibiotarsal joint edema.
Intactjointsandnormalcapsularandpericapsularsofttissue
were noted upon histopathological examination. The rOspA
vaccine preparation that was shown to prime hamsters for
induction of deleterious eﬀects is analogous to commercial
vaccine preparations [36, 37] that were licensed by the
United States Food and Drug Administration for use in
humans. These data further conﬁrm the importance of
the immunocompetent hamster model of severe destructive
Lyme arthritis for the determination of possible deleterious
eﬀects that commercial Lyme borreliosis vaccines may evoke
in mammalian hosts. As additional support, Croke et al.
[35] also demonstrated that a commercial canine rOspA
vaccine prepared in alum primed hamsters for the induction
of severe destructive Lyme arthritis upon challenge with
B. burgdorferi. Obviously, this model should be utilized
to evaluate vaccine preparations for adverse eﬀects before
clinical trials begin.
3. MurineModels of Synovitisand
SevereDestructiveLymeArthritis
3.1. Synovitis. In early investigations, it was determined
that the strain of mouse was important for the degree of
Lyme borreliosis articular involvement potentiated [38–40],
which, in turn, was correlated to the MHC haplotype of the
mouse. C57BL/6 mice (H2b) were resistant to the induction
of arthritic manifestations in spite of infection with a
large inocula of B. burgdorferi, while BALB/c mice (H2d)
developed a mild articular condition. In contrast, strains
of H2k haplotype mice, including AKR and C3H, manifest
a Lyme arthropathy upon challenge with B. burgdorferi.
The edema and synovitis observed in these infected mice
closely resembled those of adult immunocompetent LSH
hamsters challenged with B. burgdorferi [41, 42]. Endotoxin
susceptibility diﬀerences inherent to the C3H mouse did
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as endotoxin-resistant C3H/HeJ mice manifest equivalent
synovitis to that of endotoxin-susceptible C3H/HeN mice
[43].
Although the C3H mouse is the most frequently utilized
animal model to investigate the immune mechanisms of
Lyme arthritis, the model has limitations. Mice develop
synovitis within days of infection. Humans do not develop
synovitis within days after infection with B. burgdorferi.I n
addition, the arthritis in mice is mild and is not sustained.
Moreover, most C3H mice resolve the arthritis 3 to 6 weeks
after infection. Rapid resolution of arthritis also does not
occur in humans infected with B. burgdorferi. The model is
utilized to determine the early innate immune events that
occur when spirochetes enter the host after being bitten by a
Borrelia-infected tick. Therefore, this model may not mimic
the immunological events that drive the induction of severe
arthritis in humans.
3.2. Murine Models of Severe Destructive Lyme Arthritis
3.2.1. Immunodeﬁcient Mouse Models. Multiple studies [44–
46] have reported that challenge of SCID mice with B.
burgdorferiinducesaseveredestructiveLymearthritis.When
Schaible et al. [44] challenged CB.17 SCID mice subcuta-
neously in the tail with B. burgdorferi sensu stricto isolate
ZS7 or ZQ1, inoculum-dependent clinical signs of arthritis
were ﬁrst observed between days 7 and 20 after infection.
Mice developed redness and swelling of tibiotarsal joints
and were observed to have diﬃculty walking. Such manifes-
tations persisted throughout the entire observation period
of 87 days. Histopathological examination characterized
arthritic involvement as synovial hyperplasia, inﬁltration
of mononuclear leukocytes into inﬂamed synovium, and
the formation of pannus with joint erosion and cartilage
destruction. In contrast, normal CB.17 mice did not develop
any histopathological alterations following challenge with
B. burgdorferi. A subsequent study by Schaible et al. [45]
extended observations of CB.17 SCID mice to 195 days after
challenge with B. burgdorferi ZS7. Macroscopic manifesta-
tions of arthritis failed to resolve even after this interval
and severe destructive arthritic involvement progressed from
tibiotarsal joints to the metatarsal and ulnocarpal joints.
Furthermore, histopathological changes were noted in the
ligaments, tendons, fascia, and skeletal muscle.
Barthold et al. [46] also compared the progression of
Lyme arthritis in C3H/He SCID mice to that observed in
C3H/He mice. While the maximum severity and distri-
bution of arthritis were observed at relatively early inter-
vals after intradermal infection with B. burgdorferi sensu
stricto isolate N40, arthritis severity progressively worsened
in C3H/He SCID mice throughout a 60-day observation
period. Histopathological analysis of infected C3H/He SCID
mice 60 days after infection revealed very severe joint
disease involving nearly all tibiotarsi, knees, elbows, and
carpi examined. Intensely proliferating synoviocytes caused
eﬀacement of joints, tendons, and bursae. Obliteration of
the joint cavity and losses of cartilage and bone were noted.
Such characterization of histopathology is consistent with
the clinical entity of severe destructive Lyme arthritis. By
contrast, at a peak interval of articular involvement in
C3H/He mice (between 14 and 30 days after B. burgdorferi
challenge), tibiotarsal joints displayed moderate synovial
proliferation, leukocytic inﬁltration, and exudation into the
joint lumen. The immunodeﬁcient mouse model may not
represent the actual events that occur in humans. However,
themodelisimportantforunderstandingthecomponentsof
the immune response involved in the induction of arthritis.
Without this model, the complexity of the immune response
participating in the development of synovitis would be
extremely diﬃcult to decipher.
3.2.2. Irradiated Mouse Model. Irradiation of mice followed
by infection with B. burgdorferi can also induce severe
destructive Lyme arthritis. Low-passage (P<5) B. burgdor-
feri 297 was cultivated at 32◦C in Barbour-Stoenner-Kelly
(BSK) medium [47] containing screened lots of bovine
serum albumin [48]. Two groups of three C3H/HeJ mice
each were subjected to 550 rads of gamma radiation with a
60Co irradiator (Picker Corporation, Cleveland, OH). Mice
were then immediately anesthetized with methoxyﬂurane
and footpads of one group of mice were infused with 0.2mL
of a 5 × 106/mL suspension of B.burgdorferi 297. Thesecond
group of irradiated mice was injected in the footpad with
0.2mL of sterile BSK. A group of three C3H/HeJ mice, not
subject to gamma radiation, was challenged in the footpad
with 106 B. burgdorferi 297 delivered in a 0.2mL volume.
Inﬂammatory responses were assessed at the macro-
scopic level for 20 days by carefully measuring the width
and thickness of each tibiotarsal joint with a dial-type
vernier caliper (Fisher Scientiﬁc, Pittsburgh, PA), combining
these values, and determining mean dimensions within a
given group. Tibiotarsal joint edema peaked nine days after
challenge of nonirradiated mice with B. burgdorferi and
began to wane thereafter (Figure 1). By contrast, onset of
edema was slightly delayed in irradiated mice that were
challenged with B. burgdorferi, with swelling beginning to
peak 20 days after challenge (Figure 1). Both groups of mice
challenged with B. burgdorferi manifested peak edema that
was relatively equal to each other and exceeded that observed
in mice injected with BSK medium.
After 21 days of observation, mice were euthanized by
CO2 asphyxiation and hind legs of all mice were amputated
at the midfemur and ﬁxed in 10% neutral buﬀered zinc
formalin(Fisher).Whilepeakedemameasurementsbetween
infected irradiated and nonirradiated mice were similar, the
degree of arthropathy was distinctly diﬀerent between the
two treatment groups. A severe destructive Lyme arthritis
was induced in the hind legs of irradiated mice challenged
with B. burgdorferi. This was characterized, in part, by a
dense inﬁltration of inﬂammatory cells which compacted
synovial spaces and by widespread erosion of articular
cartilage and destruction of small bones (Figures 2(a) and
2(b)). This was in stark contrast to the histopathologi-
cal response of hind legs of nonirradiated mice infected
with B. burgdorferi which demonstrated a mild synovial
hyperplasia and joint spaces free of inﬂammatory cells6 Clinical and Developmental Immunology
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Figure 1: Swelling of the tibiotarsal joint detected in irradiated
C3H/HeJ mice injected with B. burgdorferi sensu stricto isolate 297
() or BSK medium () and in nonirradiated C3H/HeJ mice
infused with B. burgdorferi 297 (•).
(Figure 2(d)). Examination of histopathology from infected
nonirradiated mice at an interval (day 14) closer to that
at which peak macroscopic edema was observed revealed
a similar mild Lyme synovitis (Figure 2(c)). Mice injected
withBSKmediumfailedtopresentanyarticularinvolvement
(Figure 2(e)). Although this model is infrequently utilized,
it is valuable to assess the role of immune components in
protection and the development of severe destructive Lyme
arthritis.
3.2.3. Interferon-Gamma- (IFN-γ-) Deﬁcient Mouse Model.
Classically, a T helper lymphocyte type 1 (Th1) response
picture has been painted to explain the induction of
Lyme arthritis. Humans with clinically diagnosed Lyme
borreliosis produce increased serum levels of the Th1
cytokine IFN-γ and decreased quantities of interleukin-
(IL-) 4 when compared to healthy individuals [54]. Yang et
al. [55] noted that mice susceptible to synovitis following
B. burgdorferi infection produced increased serum levels of
IgG2a, an immunoglobulin isotype associated with a Th1
response. Independent groups [56, 57] reported that C3H
mice produced IFN-γ following B. burgdorferi infection,
while BALB/c mice, with an inherent variable susceptibility
to synovitis, produced IL-4 following challenge with B.
burgdorferi. Furthermore, treatment of BALB/c mice with
neutralizing antibody to murine IL-4 facilitated the devel-
opment of synovitis upon challenge with B. burgdorferi,
whereas treatment of C3H mice with rIL-4 or neutralizing
antibody to murine IFN-γ reduced the severity of synovitis
[56–58].
On the other hand, studies have presented instances in
which decreases in IFN-γ production or an inherent deﬁ-
ciency of IFN-γ had no impact on arthritis severity. Blockage
of the B7-CD28 interaction in BALB/c mice resulted in an
increase of IFN-γ production with no concomitant change
in synovitis [59]. Depletion of natural killer cells in C3H/HeJ
mice resulted in a loss of early IFN-γ production with no
alteration of synovitis [60]. Direct evidence not supporting a
roleforIFN-γ insynovitisinductionwaspresentedbyBrown
and Reiner [61]. Upon histopathological examination of
tibiotarsal joints, IFN-γ-deﬁcient mice that were challenged
with B. burgdorferi were shown to manifest equivalent
synovitis to that observed in infected wild-type controls.
An in vitro neutralization model [50] supplied addi-
tional evidence in support of the hypothesis that IFN-
γ does not play a signiﬁcant role in the induction of
articular manifestations of Lyme borreliosis. C3H/HeJ mice
were immunized with formalin-inactivated B. burgdorferi in
alum. Inguinal lymph node cells were cocultured with B.
burgdorferi and macrophages and were treated in vitro with
either rIFN-γ or neutralizing antibody to IFN-γ.C u l t u r e s
were incubated for 24 hours at which time contents were
infused into footpads of recipient C3H/HeJ mice. While
three-week edema measurements did not vary signiﬁcantly
between recipients of immune lymph node cells treated
with rIFN-γ or anti-IFN-γ, histopathological examination
of hind legs infused with cells treated in vitro with anti-
IFN-γ manifested severe destructive Lyme arthritis [50]. In
contrast,bothrecipientsofimmunelymphnodecellstreated
in vitro with rIFN-γ and recipients of nontreated cultures of
cells obtained from vaccinated or nonvaccinated C3H/HeJ
mice demonstrated synovitis.
A clearer picture of the role of IFN-γ on the development
of severe destructive Lyme arthritis was shown by Christo-
pherson et al. [51]. When C57BL/6 IFN-γ-deﬁcient mice
were vaccinated with Formalin-inactivated B. burgdorferi in
alum, gross tibiotarsal edema and a corresponding severe
destructive arthritis were induced upon footpad challenge
with a heterologous isolate of B. burgdorferi [51]. Challenge
of nonvaccinated mice produced only a mild synovitis and
tibiotarsal joint measurements that were signiﬁcantly less
than those observed in vaccinated mice but slightly greater
thanthosemeasuredinIFN-γ-deﬁcientmiceinoculatedwith
BSK medium. These data corroborated those of Brown and
Reiner [61] that IFN-γ is not required for the development
of arthropathy in an infection model of murine Lyme
borreliosis.
The ﬁndings of Christopherson et al. [51] also suggested
that inﬂammatory pathways other than a traditional Th1,
IFN-γ-mediated response may stimulate the development
of severe destructive Lyme arthritis following infection with
B. burgdorferi. Using the IFN-γ-deﬁcient murine model,
Burchill et al. [52] demonstrated a signiﬁcant role for the
proinﬂammatory cytokine IL-17 in the induction of severeClinical and Developmental Immunology 7
(a) (b)
(c) (d)
(e)
Figure 2: Histopathological responses detected in irradiated ((a) and (b)) and nonirradiated ((c) and (d)) C3H/HeJ mice injected with B.
burgdorferi sensu stricto isolate 297. Irradiated control mice (e) were injected with BSK medium. All specimens were acquired 21 days after
challenge, with the exception of panel (c), day 14. Panels (a) and (b) were viewed with a 4x or 10x objective lens, respectively.
destructive Lyme arthritis. When these mice were vaccinated
and challenged three weeks later with a heterologous bac-
terial strain in the footpad, they developed inﬂammatory
changes analogous to those observed by Christopherson et
al. [51]. However, administration of antibodies to either IL-
17 or the IL-17 receptor on the day of infection and daily
thereafterfor11daysreducedtheseverityofhindpawedema
and abrogated the development of severe destructive Lyme
arthritis [52].
These ﬁndings were extended by Nardelli et al. [53]
who showed that administration of anti-IL-17 to Borrelia-
vaccinated and -infected IFN-γ-deﬁcient C57BL/6 mice also
correlated with an inordinate increase in the numbers of
CD4+CD25+ T lymphocytes in local lymph nodes. Con-
comitantdepletionofIL-17andCD4+CD25+ Tlymphocyt es
from these Borrelia-vaccinated and -infected mice resulted
in massive edema of the hind paws, extensive erosion of
cartilage, bone, and synovial tissue of the tibiotarsal joints,
and pannus formation into the joint space, indicating that
these cells played a signiﬁcant role in the protection from
Borrelia-induced arthritis mediated by neutralization of IL-
17 [53]. In support of this, depletion of only CD4+CD25+
Tl y m p h o c y t e sf r o mBorrelia-vaccinated and -infected mice
resultedininﬂammatorychangessimilartothoseofBorrelia-
vaccinated and -infected control mice [62]. Signiﬁcantly,
adoptive transfer of CD4+CD25+ T lymphocytes obtained
from anti-IL-17-treated Borrelia-vaccinated and -infected
mice wholly prevented histopathological changes of the hind
paws [63]. This suggested that those CD4+CD25+ Tl y m -
phocytes which developed in the absence of IL-17-mediated
inﬂammation conferred protection against the induction
of arthritis. Therefore, the development of arthritis in this
murine model may be attributed to the combined eﬀects
of IL-17 production and a correspondingly low presence of
CD4+CD25+ T lymphocytes. These ﬁndings were obtained
using IFN-γ-deﬁcient mice, which allows investigators to
determine the interaction among cytokines that directly or
indirectly are aﬀected by IFN-γ.8 Clinical and Developmental Immunology
Table 1: Hamster and murine models important for evaluation of the pathogenesis of severe destructive Lyme arthritis.
Model B. burgdorferi
strains
Timing of arthritogen
delivery Result Comments Reference(s)
Immunocompetent
hamster (challenge) Numerousa Can vary Synovitis Studying innate responses [18]
Immunocompetent
mouse (challenge) Numerousa Can vary Synovitis Studying innate responses [38–42]
Irradiated hamster
(challenge) Numerousa Following 550 rads
gamma radiation SDLAb
Insight into cellular
components responsible for
SDLA
[18, 19]
Irradiated mouse
(challenge) 297 Following 550 rads
gamma radiation SDLA
Insight into cellular
components responsible for
SDLA
Stated in this
publication
SCID mouse (challenge) Numerous Can vary SDLA
Insight into cellular
components responsible for
SDLA
[44–46]
Immunocompetent
hamster
(vaccination/challenge)
Numerousc
Challenge prior to
development of
signiﬁcant borreliacidal
antibody titer
(homologous challenge)d;
timing of heterologous
strain challenge can vary
SDLA
Insight into adoptive
cellular components
responsible for SDLA in an
immunocompetent host
[20, 30–34]
Immunocompetent
mouse
(vaccination/challenge)
297 Challenge following 21
days of vaccination SDLA
Elucidating adoptive
immunological pathways of
SDLA in an
immunocompetent host
[49]
In vitro murine IFN-γ
neutralization 297 Lymph node cells pulsed
in vitro SDLA
Addition of IFN-γ to
lymph node cells prior to in
vitro B. burgdorferi pulse;
footpad challenge of na¨ ıve
mice following cell culture
transfer; Assessment of
arthritogenic potential of B.
burgdorferi immunogens
[50]
IFN-γ-deﬁcient mouse
(vaccination/challenge) 297 Challenge following 21
days of vaccination SDLA Elucidating immunological
pathways of SDLA [51–53]
aReferenced study(ies) focused on B. burgdorferi sensu stricto isolate 297.
bS e v e r ed e s t r u c t i v eL y m ea r t h r i t i s .
cReferenced study(ies) focused on B. bissettii vaccination with subsequent B. burgdorferi sensu stricto isolate 297 challenge.
dAt least six seroprotective groups have been characterized ([27–29]).
Collectively, these ﬁndings not only provided potentially
valuable insights into the pathogenesis of severe destructive
Lyme arthritis, but also have played a signiﬁcant role in
elucidating immunological pathways beyond the realm of
Lyme borreliosis. In support of this statement, Codolo et
al. [64] showed that synovial T lymphocytes isolated from
humans with Lyme arthritis secrete IL-17 upon stimulation
with neutrophil activating protein A of B. burgdorferi.I n
addition, Shen et al. [65] observed the presence of Th17 cells
in the synovial ﬂuid of humans with Lyme arthritis; however,
their direct role in mediating the induction or propagation
of Lyme arthritis was not determined. Moreover, these early
investigations of the role of IL-17 in the development of
murine Lyme arthritis were used to support the seminal
immunological ﬁndings of Bettelli et al. [66] that Th17 cells
and CD4+CD25+Foxp3+ regulatory T lymphocytes develop
in a reciprocal manner from a common precursor cell, and
that this development is governed by the presence or absence
of an inﬂammatory environment.
3.2.4. Immunocompetent Mouse Model of Severe Destructive
Lyme Arthritis. Although use of IFN-γ-deﬁcient mice to
study the role of cytokines in the development of severe
destructive Lyme arthritis is valuable, severe arthritis can
also be induced in C57BL/6 mice. Mice are vaccinated in
the inguinal region with washed spirochetes mixed with 1%
alum. Approximately three weeks after vaccination, mice are
challenged with viable B. burgdorferi. This animal model was
utilized to determine the role of IL-35 on the production of
IL-17 [49].
IL-35 is a major cytokine produced by CD4+CD25+
Foxp3+ regulatory T lymphocytes. Based on previous ﬁnd-
ings that administration of anti-IL-17 prevented arthritis inClinical and Developmental Immunology 9
Table 2: Hamster models important for evaluation of protective immunity versus endpoint of severe destructive Lyme arthritis.
Model B. burgdorferi
strains
Timing of immunogen
delivery Endpoint Comments Reference(s)
Irradiated hamster
(challenge) Numerousa Following 550 rads gamma
radiation SDLAb Adoptive transfer
(protection) experiments [18, 21, 22]
Irradiated hamster
(vaccination/challenge) Numerousa
Challenge prior to
development of signiﬁcant
borreliacidal antibody titer
(homologous challenge)c;
timing of heterologous
strain challenge can vary
SDLA Assessment of vaccine
candidates [24]
Immunocompetent
hamster
(vaccination/challenge)
Numerousd
Challenge prior to
development of signiﬁcant
borreliacidal antibody titer
(homologous challenge)c;
timing of heterologous
strain challenge can vary
SDLA
Characterizing duration of
protective immunity of
vaccine candidates;
Assessing Lyme borreliosis
vaccine candidates for
adverse events
[20, 25]
[29, 35]
aReferenced study(ies) focused on B. burgdorferi sensu stricto isolate 297.
bS e v e r ed e s t r u c t i v eL y m ea r t h r i t i s .
cAt least six seroprotective groups have been characterized ([27–29]).
dReferenced study(ies) focused on B. bissettii vaccination with subsequent B. burgdorferi sensu stricto isolate 297 challenge.
Borrelia-vaccinated and -infected mice and induced produc-
tion of CD4+CD25+ T lymphocytes with immunoregulatory
function, we hypothesized that IL-35 would decrease the
severity of arthritis by inhibiting the production of IL-17
in Borrelia-vaccinated and -infected mice. When IL-35 was
administered to Borrelia-vaccinated and -infected mice, IL-
35 enhanced arthritis. This suggests that IL-35 does not
play a major role in preventing the induction of arthritis.
Additional investigations are needed to determine which
cytokines are responsible for the induction and resolution
of arthritis. These studies are important because they may
lead to a therapeutic agent that may decrease the eﬀects
of arthritis. The mouse model of severe destructive Lyme
arthritis yields reproducible data and hopefully the results
can be applied to humans with Lyme arthritis.
4.A UnifyingHypothesis
Using the data obtained through the investigation of hamster
and mouse models, as well as through analysis of human
tissues ex vivo, a unifying hypothesis can be developed
to elucidate the mechanisms by which severe destructive
Lyme arthritis is induced. Central to the development of
this chronic manifestation are (1) the stimulation of innate
immune eﬀectors following infection with B. burgdorferi,
with subsequent stimulation of adaptive immune mecha-
nisms; (2) survival and persistence of the spirochete in the
face of a robust innate immune response and increasing
(but eventually waning) borreliacidal antibody titers, and (3)
recognition ofB.burgdorferior itsproteins byprimed Tlym-
phocytes, with ensuing tissue-destructiveeﬀectsoccurring in
the joint.
Upon bloodmeal acquisition by infected Ixodes spp.,
host macrophages, dendritic cells, and/or their monocyte
precursors rapidly recognize lipoproteins of B. burgdorferi
via Toll-like receptor 2. Processing of the spirochete by these
cells stimulates the secretion of various cytokines, such as
tumor-necrosis factor-α, interleukin-1β, and interleukin-6,
[64, 67], which serve to recruit neutrophils and amplify the
early inﬂammatory events manifesting as synovitis. Some
spirochetessurvivethisinitialinnateimmunedefense,aswell
as the borreliacidal antibody response triggered by innate
eﬀectors. B. burgdorferi disseminates to the articular tissues,
where the spirochetes or their proteins may be recognized
weeks, months, or years later to activate a new wave of innate
immunity as well as previously primed adaptive immune
cells. Innate immune cells in the synovial tissues and/or ﬂuid
mayagainsecreteanarrayofcytokines,includingtransform-
ing growth factor-β, IL-6, IL-12 (among others) that polarize
the T lymphocyte response toward inﬂammatory subsets
such as Th1 and Th17 cells. In turn, the immune response
would be directed away from T lymphocyte subsets, such as
Th2 and regulatory T lymphocytes, which antagonize these
inﬂammatory populations. Both Th1 and Th17 responses
have been postulated to play a role in later-stage Lyme
arthritis [68], which is supported by observation of these
cells in the synovial ﬂuid of humans with Lyme arthritis
[65], implication of their prototypical cytokines in disease
[52, 69], and recognition that these cytokines induce severe
destruction in other models of arthritis [70, 71]. These
inﬂammatory responses may persist until the antigenic
stimulus is eventually cleared, at which point regulatory T
lymphocytes may mediate suppression of inﬂammation and
tissue remodeling may occur.
5. Conclusions
Selection of the proper animal model is paramount in
relevant investigations of articular involvement of Lyme
disease.DeliveryofB.burgdorferitoimmunocompetentLSH
hamsters and C3H mice elicits a mild and transient synovitis
that mimics pathology observed in individuals in early Lyme10 Clinical and Developmental Immunology
borreliosis. However, in order to investigate the chronic
destructive arthropathy with which a certain subpopulation
of individuals in late Lyme borreliosis may be aﬄicted, one
mustchooseeithertheimmunocompetent hamstermodelof
severe destructive Lyme arthritis or various murine models
of severe destructive Lyme arthritis that manifest a degree of
immunodeﬁciency (Table 1).
Whilemurinemodels,withtheirrepletearmamentarium
of immunological reagents, appear very promising in the
future study of severe destructive Lyme arthritis, we do not
intend to eulogize the hamster model of severe destructive
Lyme arthritis. The immunocompetent hamster model of
severe destructive Lyme arthritis can be a very advantageous
system for safety assessment of Lyme borreliosis vaccine
preparations (should redevelopment eﬀorts ever come to
fruition [72, 73]) due to the fact that macroscopic obser-
vation of footpad edema correlates well with the severity of
histopathology (Table 2).
Murine systems of severe destructive Lyme arthritis will
provide a tremendous advantage in the future elucida-
tion of immunological mechanisms that result in severe
destructive Lyme arthritis. In particular, the advent of a
system in which immune cells from an immunocompetent
host are programmed in vitro to elicit severe destructive
Lyme arthritis upon subsequent transfer into a recipient
immunocompetent host presents great potential in the
ultimate elucidation of the mechanisms of severe destructive
Lyme arthritis. In addition, this system may also allow
for simultaneous assessment of Lyme borreliosis vaccine
candidates (following selection of protective epitopes [74])
for production of protective borreliacidal antibodies in vitro
[50, 75–78] as well as the deleterious capability of priming
recipients for induction of severe destructive Lyme arthritis
[50]. Taken together, these investigations may contribute to
the production of a safe and eﬃcacious vaccine to prevent B.
burgdorferi infection.
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